NuCel

Nucel Biotecnologia is a Brazilian biotechnology company specializing in the development and production of recombinant human proteins and advanced cell therapies. Originally established as a spin-off from the University of São Paulo (USP), the company operates at the intersection of academic research and industrial biomanufacturing. Its primary focus is on creating high-value biosimilars and innovative biological treatments for complex conditions such as hemophilia, multiple sclerosis, and chronic kidney disease. Nucel's infrastructure includes state-of-the-art laboratories for molecular biology and large-scale cell culture, positioning it as a key player in South America's biologics sector. The company also engages in cutting-edge research into stem cell applications for neurodegenerative and metabolic disorders.